RUBRAMIN PC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rubramin Pc, and what generic alternatives are available?
Rubramin Pc is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in RUBRAMIN PC is cyanocobalamin. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rubramin Pc
A generic version of RUBRAMIN PC was approved as cyanocobalamin by PADAGIS ISRAEL on September 9th, 2020.
Summary for RUBRAMIN PC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Patent Applications: | 57 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RUBRAMIN PC at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for RUBRAMIN PC
US Patents and Regulatory Information for RUBRAMIN PC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | RUBRAMIN PC | cyanocobalamin | INJECTABLE;INJECTION | 006799-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | RUBRAMIN PC | cyanocobalamin | INJECTABLE;INJECTION | 006799-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | RUBRAMIN PC | cyanocobalamin | INJECTABLE;INJECTION | 006799-010 | Apr 28, 1988 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |